You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 4, April 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  OBSERVATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Effect of Topical Tretinoin on Dysplastic Nevi

A Preliminary Trial

Libby Edwards, MD; Philip Jaffe, MD

Arch Dermatol. 1990;126(4):494-499.


Abstract

• Twenty-one patients were enrolled in a randomized, double-blind study that examined the effects of topical 0.05% tretinoin (all-trans-retinoic acid; vitamin A acid; Retin-A) solution on dysplastic nevi. Following histologic confirmation of the diagnosis of dysplastic nevus in three representative lesions, patients applied either tretinoin or a placebo containing 50% alcohol to selected dysplastic nevi once a day under tape occlusion, or twice a day unoccluded, for 4 months. Immediate posttreatment comparative photographs showed marked fading or elimination of some dysplastic nevi clinically, and histologic examination of excisional biopsy specimens showed disappearance or reversion to benign nevi in many of the treated lesions. There were no clinical or histologic changes in those dysplastic nevi treated with placebo. This study shows a definite biological effect of topical tretinoin on some dysplastic nevi.

(Arch Dermatol. 1990;126:494-499)



Author Affiliations

From the Departments of Internal Medicine, Section of Dermatology (Dr Edwards), and Internal Medicine (Dr Jaffe), University of Arizona College of Medicine, Tucson.


Footnotes

Accepted for publication October 27, 1989.

Presented in part at the 47th annual meeting of the American Academy of Dermatology, Washington, DC, December 7, 1988.

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Chemoprevention of Melanoma: An Unexplored Strategy
Demierre and Nathanson
JCO 2003;21:158-165.
ABSTRACT | FULL TEXT  

Advances in the Development of Retinoids as Chemopreventive Agents
Lippman and Lotan
J. Nutr. 2000;130:479-479.
ABSTRACT | FULL TEXT  

No Effect of Topical Tretinoin on Lentigo Maligna
Rivers and McCarthy
Arch Dermatol 1991;127:129-129.
ABSTRACT  

Dysplastic Melanocytic Nevi: Normal Variants or Melanoma Precursors?
Murphy and Halpern
Arch Dermatol 1990;126:519-522.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.